Trust Signals
Key Takeaways
- Enclomiphene is not FDA-approved as a standalone drug. It is legally available in the US only via compounding pharmacy with a valid physician prescription.
- Phase II and III trials by Repros Therapeutics (ZA-002, ZA-004) showed enclomiphene at 12.5 mg to 25 mg daily raised serum testosterone while preserving sperm count, unlike exogenous testosterone therapy.
- The single most important purity check is requesting an HPLC-verified certificate of analysis confirming enclomiphene (trans-isomer) content and the absence of residual zuclomiphene (cis-isomer).
- Research chemical vendors sell enclomiphene without a prescription, but their products are not manufactured under GMP and independent third-party testing has found frequent dosing inaccuracies in this category.
- WADA classifies enclomiphene as a prohibited SERM; competitive athletes under anti-doping rules cannot use it legally regardless of source.
What Is the Best Place to Buy Enclomiphene?
The best place to buy enclomiphene in 2026 is through a licensed US telehealth men's health platform that requires baseline blood work, writes a legal prescription, and dispenses through a PCAB-accredited or 503B-registered compounding pharmacy. This route guarantees prescription oversight, pharmacist review, GMP-standard manufacturing, and a traceable certificate of analysis. Research chemical vendors skip every one of those safeguards.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What are the legal routes to obtain enclomiphene?
- How do the main source types compare?
- What does the clinical evidence actually show?
- How does enclomiphene work at the receptor level?
- What most pages get wrong about enclomiphene
- How to verify purity and read a COA
- Honest head-to-head: enclomiphene vs. TRT vs. clomiphene
- Dosing, monitoring, and what labs to track
- Side effects and failure modes
- FAQ
- Sources
What Are the Legal Routes to Obtain Enclomiphene?
In the United States, enclomiphene occupies a specific regulatory category. It is not an FDA-approved drug on its own. It is not a controlled substance under the DEA schedules. It can be legally compounded and dispensed to a patient with a valid prescription from a licensed prescriber, under FDA's compounding regulations (21 USC 503A for patient-specific compounding, 503B for outsourcing facilities).
Practically, that means two functional routes for a US resident:
- In-person men's health clinic or urologist/endocrinologist. A physician evaluates your labs (total testosterone, LH, FSH, estradiol), determines hypogonadism with an intact pituitary axis, and sends a prescription to a compounding pharmacy. This is the highest-oversight route.
- Telehealth men's health platform. Platforms such as Maximus, Defy Medical, Marek Health, and similar services can order labs, evaluate results asynchronously or via video visit, and prescribe enclomiphene to be filled at a partnered compounding pharmacy. Quality varies significantly by platform; see the criteria checklist below.
How Do the Main Source Types Compare?
| Source Type | Prescription Required | GMP Manufacturing | COA Available | Isomer Purity Verified | Legal Status (US) | Typical Cost per Month |
|---|---|---|---|---|---|---|
| 503B Outsourcing Compounding Pharmacy (via Rx) | Yes | Yes (FDA-registered) | Yes | Yes, if HPLC tested | Legal | $60 to $150 |
| 503A Patient-Specific Compounding Pharmacy (via Rx) | Yes | State-licensed, USP standards | Varies | Varies by pharmacy | Legal | $50 to $120 |
| Telehealth Platform (prescribes and connects to pharmacy) | Yes (included in service) | Depends on partner pharmacy | Often yes | Often yes | Legal | $100 to $200 (includes consultation) |
| Research Chemical Vendor | No | No | Sometimes (self-reported) | Rarely independently verified | Gray/illegal for human use | $30 to $80 |
| International Online Pharmacy (unverified) | Varies | Unknown | Rarely | Rarely | Import risk, unregulated | $40 to $100 |
What Does the Clinical Evidence Actually Show?
Evidence Ledger
| Claim | Best Evidence Type | Key Study | Effect Direction | Confidence |
|---|---|---|---|---|
| Enclomiphene raises serum testosterone in hypogonadal men | Phase II/III RCT | Repros ZA-002, ZA-004 trials | Positive (testosterone increased at 12.5 mg and 25 mg daily) | Moderate |
| Enclomiphene preserves sperm count vs. TRT | Phase III RCT comparison arm | Wiehle et al. 2014 (Int J Andrology) | Positive (sperm count maintained or increased) | Moderate |
| Lower estrogenic side effects than racemic clomiphene | Mechanistic + small clinical comparison | Pharmacokinetic analyses of isomer half-lives | Directionally positive (less zuclomiphene accumulation) | Low |
| Long-term cardiovascular safety | No long-term RCT data | None available | Unknown | Very Low |
| Improvement in symptoms of hypogonadism (energy, libido, mood) | Secondary endpoints in RCTs; no dedicated QoL RCT | ZA-004 secondary data | Directionally positive but not primary endpoint | Low |
| Safe and effective in men with obesity-related hypogonadism | Subgroup analysis | Kim et al. referenced in Repros NDA documentation | Positive in subgroup | Low |
The honest caveat: Repros Therapeutics' NDA was not approved by the FDA. The agency's complete response letter cited the need for additional data. This does not mean enclomiphene does not work; it means the long-term safety profile sufficient for mass-market approval has not been established in the way the FDA requires. The short-term efficacy signal is real.
How Does Enclomiphene Work at the Receptor Level?
Enclomiphene is the trans-geometric isomer of clomiphene. It is a selective estrogen receptor modulator (SERM). Its primary mechanism in men is competitive antagonism at estrogen receptors in the hypothalamus and pituitary. When hypothalamic estrogen receptors are blocked, the feedback inhibition that estrogen normally exerts on GnRH pulsatility is removed. The hypothalamus increases GnRH pulse frequency and amplitude, which drives increased LH and FSH secretion from the anterior pituitary. LH stimulates Leydig cell testosterone synthesis; FSH supports Sertoli cell function and spermatogenesis.
What this mechanism does NOT prove: blocking estrogen feedback raises LH, and LH raises testosterone, but the magnitude of the downstream testosterone response depends entirely on the functional reserve of the individual's Leydig cells. In men with primary hypogonadism (testicular failure), enclomiphene will raise LH and FSH but will not substantially raise testosterone because the target cells cannot respond. Enclomiphene is a treatment for secondary (hypothalamic-pituitary) hypogonadism, not primary hypogonadism. This is the single most important clinical selection criterion and the most commonly misunderstood point.
Zuclomiphene, the cis-isomer in racemic clomiphene, has an estimated half-life measured in weeks compared to enclomiphene's half-life of roughly 10 hours (based on pharmacokinetic data cited in the Repros NDA documentation). Zuclomiphene accumulates with daily dosing and has partial agonist activity at some estrogen receptor subtypes, which is the pharmacological basis for the visual and mood side effects associated with long-term Clomid use. Enclomiphene, taken alone, avoids that accumulation.
What Most Pages Get Wrong About Enclomiphene
This is the section commodity pages skip entirely.
1. Isomer contamination in compounded products is a real risk. Enclomiphene is synthesized from clomiphene or from precursors, and the manufacturing process requires isomer separation. If the compounding pharmacy's raw API supplier did not achieve clean separation, the "enclomiphene" product may contain meaningful amounts of zuclomiphene. A COA that only reports "clomiphene" or "clomiphene citrate" without specifying trans-isomer content is not a sufficient purity guarantee. Always ask the pharmacy whether the API was tested specifically for the trans/cis ratio using HPLC or chiral column chromatography.
2. "Research chemical" COAs are not independent verification. Many research vendors post COAs on their websites. The majority of these are produced by the same supplier who sold them the powder, not by a third-party accredited laboratory. An independent COA requires the buyer to send a sample to a lab like Janoshik, Labdoor, or an ISO-17025 accredited analytical facility. Self-reported vendor COAs have been shown in multiple community-sourced testing projects to have significant discrepancies from actual content.
3. Enclomiphene does not work for primary hypogonadism. Any source or page presenting enclomiphene as a general testosterone booster without this caveat is omitting the most clinically important selection criterion. If your LH and FSH are already elevated and your testosterone is low, your testes cannot respond, and enclomiphene will not help you.
4. Oral bioavailability is high, but food timing matters less than isomer purity. Most pages discuss storage or timing rules without noting that the biggest variable in enclomiphene response is whether the product you received actually contains pure enclomiphene rather than a mixed isomer ratio.
How to Verify Purity and Read a COA for Enclomiphene
When you receive a product or before you fill a compounding prescription, request the following documentation and check these specific items:
- Active ingredient identity: Should read "enclomiphene citrate" or "enclomiphene (trans-clomiphene)," not just "clomiphene citrate."
- Assay percentage: HPLC assay of the active ingredient should be 98% or higher for a pharmaceutical-grade API.
- Isomer purity / chiral purity: This is the critical number most COAs omit. Ask specifically: "What is the trans-isomer content confirmed by chiral HPLC?" A legitimate pharmacy sourcing clean API should be able to answer this.
- Heavy metals: USP standards require testing for lead, arsenic, cadmium, and mercury. Confirm limits are within USP 232/233.
- Testing laboratory: Confirm the lab name. For a compounding pharmacy, this may be their in-house or contracted analytical lab. For research chemicals, demand a third-party lab COA, not a supplier COA.
- Lot number and expiration date: Should match the product you received. A COA with no lot number is not product-specific and is nearly meaningless as a quality guarantee.
What a degraded or mislabeled product looks like: Enclomiphene citrate capsules should be a white to off-white powder. Discoloration (yellow, tan, gray) in the capsule powder suggests oxidative degradation or API impurities. Solutions or suspensions that have precipitated or changed color should not be used. There is no validated at-home test for isomer content; laboratory HPLC is the only reliable method.
Honest Head-to-Head: Enclomiphene vs. TRT vs. Clomiphene
| Criterion | Enclomiphene | Testosterone Replacement Therapy (TRT) | Racemic Clomiphene (Clomid) |
|---|---|---|---|
| FDA approval for male hypogonadism | No | Yes (injectable and gel formulations) | No (approved only for female ovulation induction) |
| Testosterone elevation magnitude | Moderate (endogenous ceiling applies) | High (supraphysiologic possible) | Moderate (similar to enclomiphene) |
| Fertility preservation | Yes (maintains/raises sperm count) | No (suppresses LH/FSH, reduces sperm count) | Yes (same mechanism as enclomiphene) |
| Long-term safety data | Limited (years, not decades) | Extensive (decades of clinical use) | Moderate (decades of use in women; less data in men) |
| Estrogen accumulation risk | Lower than racemic clomiphene | Possible (aromatization of exogenous T) | Higher (zuclomiphene accumulation) |
| Mood/visual side effects | Low to moderate | Mood effects possible; no visual SERM effects | More common with long-term use |
| Oral administration | Yes | Mostly injectable or topical (oral testosterone available but less common) | Yes |
| Where enclomiphene LOSES | Loses to TRT on magnitude and consistency of testosterone increase; loses to TRT on length of safety record; cannot override primary hypogonadism | N/A | N/A |
Dosing, Monitoring, and What Labs to Track
Clinical trials used 12.5 mg and 25 mg once daily oral dosing. Most compounding prescriptions for secondary hypogonadism follow this range. Starting at 12.5 mg daily with a lab recheck at 6 to 8 weeks is a reasonable protocol, consistent with Repros trial design.
Labs to obtain before starting: Total testosterone (morning draw, two measurements on separate days per Endocrine Society guidelines), LH, FSH, estradiol (sensitive assay), complete blood count, comprehensive metabolic panel, and ideally a semen analysis if fertility is a concern.
Labs to recheck at 6 to 8 weeks: Total testosterone, estradiol, LH, FSH. If estradiol rises substantially above the normal male range (generally above 50 pg/mL on a standard assay, though labs vary), the prescriber may adjust dose or add an aromatase inhibitor. If LH and FSH rise but testosterone does not, consider the possibility of primary hypogonadism in the differential.
Reconstitution note: Compounded enclomiphene is almost always dispensed as premeasured oral capsules; reconstitution math is not applicable here as it would be for injectable peptides. Verify the labeled dose matches your prescription and confirm capsule fill weight is consistent.
Side Effects and Failure Modes
In Repros clinical trials the most commonly reported adverse events were headache and nausea, generally mild and transient. Elevated estradiol was seen in a subset of subjects and in some cases required dose adjustment. Visual disturbances, the side effect most associated with long-term racemic clomiphene use, were reported at lower frequency with enclomiphene alone, consistent with the removal of accumulating zuclomiphene, but were not entirely absent in trial reports.
Failure modes to anticipate before starting:
- No testosterone response: Most likely cause is underlying primary hypogonadism (testicular failure). Elevated baseline LH or FSH before starting is the warning sign.
- Testosterone rises but symptoms do not improve: Symptoms of hypogonadism have multiple causes; testosterone normalization does not guarantee symptom resolution in all cases.
- Estradiol rises disproportionately: Some men aromatize aggressively. Rising estradiol with adequate testosterone may require dose reduction or adjunct management.
- Product contains wrong isomer ratio: Described in the purity section above. This is the most insidious failure mode because the user assumes they are taking enclomiphene when they may be taking a zuclomiphene-heavy mixture.
FAQ
What is the best place to buy enclomiphene legally?
The safest and most legally straightforward route in the United States is through a licensed telehealth platform or men's health clinic that prescribes enclomiphene via a compounding pharmacy registered with the FDA. This ensures prescription oversight, pharmacist review, and a dispensed product with a documented certificate of analysis.
Is enclomiphene FDA-approved?
No. As of 2026, enclomiphene has not received FDA approval as a standalone drug. A New Drug Application was pursued by Repros Therapeutics but was not approved. It can be legally dispensed in the US only through licensed compounding pharmacies operating under a valid prescription.
Can I buy enclomiphene without a prescription?
In the United States you cannot legally purchase enclomiphene without a prescription. Research chemical vendors sell it without one, but those products are not intended for human use, are not manufactured under GMP conditions, and carry real purity and contamination risks.
How is enclomiphene different from clomiphene (Clomid)?
Clomiphene is a mixture of two geometric isomers: roughly 62% zuclomiphene (cis) and 38% enclomiphene (trans). Enclomiphene is the isomer responsible for the LH and FSH stimulation. Zuclomiphene has a much longer half-life and accumulates, contributing to mood changes and visual disturbances. Enclomiphene alone aims to deliver the testosterone-stimulating benefit with reduced estrogenic accumulation.
What clinical evidence supports enclomiphene for low testosterone?
Phase II and Phase III trials sponsored by Repros Therapeutics (ZA-002 and ZA-004) showed enclomiphene raised serum testosterone while preserving sperm count. The FDA did not approve the NDA, citing the need for additional long-term safety data. Evidence quality is Moderate for short-term testosterone elevation and Low for long-term outcomes.
What dose of enclomiphene is typically prescribed?
Clinical trials used 12.5 mg and 25 mg taken orally once daily. Most compounding prescriptions for hypogonadism fall in the 12.5 mg to 25 mg daily range. Dose should be determined by a prescribing clinician based on baseline labs.
How do I verify the purity of a compounded enclomiphene product?
Request a certificate of analysis from the dispensing pharmacy. A legitimate COA should list enclomiphene citrate with confirmed HPLC assay percentage (ideally 98% or higher), chiral purity confirming trans-isomer content, lot number, and expiration date. PCAB-accredited or 503B-registered pharmacies provide an additional quality signal.
What are the main side effects of enclomiphene?
In Repros trials, the most commonly reported side effects were headache and nausea. Visual symptoms associated with racemic clomiphene were reported at lower rates. Elevated estradiol occurs in a subset of users. Long-term cardiovascular and hepatic data are limited.
Is enclomiphene detectable on a drug test?
Yes. WADA prohibits clomiphene and its isomers, including enclomiphene, under the SERM class. Competitive athletes subject to anti-doping rules should not use enclomiphene. Standard workplace urine panels do not test for it, but targeted sports testing does.
How does enclomiphene compare to testosterone replacement therapy?
TRT reliably raises serum testosterone with decades of safety data but suppresses LH and FSH, reducing sperm production. Enclomiphene preserves or raises LH and FSH, maintaining fertility. Testosterone increases with enclomiphene are generally more modest and variable than with TRT. For men who want to preserve fertility, enclomiphene is a clinically reasonable option.
What should I look for when choosing a telehealth provider for enclomiphene?
Look for a provider that requires baseline bloodwork before prescribing, uses a licensed US compounding pharmacy, offers follow-up lab monitoring at 4 to 8 weeks, and has board-certified physicians on staff. Avoid platforms that prescribe without labs or ship from outside the US.
Can women use enclomiphene?
Racemic clomiphene is FDA-approved for ovulation induction in women. Enclomiphene alone has not been approved for female use, and clinical trial data in women for enclomiphene specifically is very limited. Any off-label use in women should be under close supervision of a reproductive endocrinologist.
Sources
- Wiehle RD, Fontenot GK, Wike J, Hsu K, Nydell J, Fontenot R. "Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone." Fertility and Sterility. 2014;102(3):720-727.
- Wiehle R, Cunningham GR, Pitteloud N, et al. "Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study." BJU International. 2013;112(8):1188-1200.
- US Food and Drug Administration. Complete Response Letter to Repros Therapeutics re: NDA 022143 (Androxal/enclomiphene citrate). FDA.gov. [Referenced in Repros Therapeutics 10-K SEC filings, 2016.]
- US Code Title 21, Section 503A and 503B. Compounding of drug products. FDA.gov.
- World Anti-Doping Agency. 2026 Prohibited List. WADA-ama.org. Section S4: Hormone and Metabolic Modulators (SERMs).
- Endocrine Society Clinical Practice Guideline. "Testosterone Therapy in Men with Hypogonadism." Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1715-1744.
- Kaminetsky J, Werner M, Fontenot G, Wiehle RD. "Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone." Journal of Sexual Medicine. 2013;10(6):1628-1635.
- USP General Chapter 232/233. Elemental Impurities. United States Pharmacopeia.
- Pharmacy Compounding Accreditation Board (PCAB). Accreditation standards. pcab.net.